Evidence map›Paper›PMID 35976386›Full record

ArticleArchives of gynecology and obstetrics2022

Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis.

Rosa Freudenreich, Martin Weiss, Tobias Engler, Felix Neis, Melanie Henes

Open access · hybridAbstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.IEEE journal of translational engineering in health and medicine · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rosa FreudenreichDepartment of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.
Martin WeissDepartment of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.
Tobias EnglerDepartment of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.
Felix NeisDepartment of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany.
Melanie HenesDepartment of Women's Health, University Hospital Tübingen, Calwerstraße 7, 72076, Tübingen, Germany. melanie.henes@med.uni-tuebingen.de.
University Children's Hospital Tübingen · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe diagnosis of cervical intraepithelial neoplasia during pregnancy poses a great challenge to the treating clinician and the patient. According to the current guidelines, watchful waiting during pregnancy can be justified. Only in cases of invasion, immediate treatment may be indicated. However, few data are available on the management of cervical dysplasia during pregnancy. Further research is important for counselling affected women.

methodsData of pregnant patients with suspected cervical dysplasia who presented to the University Women's Hospital Tübingen between 2008 and 2018 were evaluated retrospectively. Colposcopic, cytologic, and histologic assessment was performed for diagnosis. Data on remission, persistence and progression of disease based on histologic and cytologic assessment and the mode of delivery were correlated.

results142 patients were enrolled. Cytology at first presentation was PAPIII (-p/-g) in 7.0%, PAPIIID (IIID1/IIID2) in 38.7%, PAPIVa (-p/-g) in 50.0%, PAPIVb (-p) in 2.8%, and PAPV (-p) in 1.4%. All cases with suspected invasion were recorded at the initial presentation. Complete histological or cytological remission was observed in 24.4%, partial remission in 10.4%, persistence in 56.3%, and progression in 8.9%. In two cases (1.5%) progression to squamous cell carcinoma occurred.

conclusionsWatchful waiting for cervical intraepithelial neoplasia during pregnancy seems to be sufficient and oncologically safe. It is important to exclude invasion during pregnancy, to perform frequent colposcopic, cytologic and histologic examinations and to ensure a postpartum follow-up examination to initiate the treatment of high-grade lesions. Spontaneous delivery seems to be safe in patients with cervical dysplasia, Caesarean section is not indicated.

Indexed as

Pregnancy Complications, NeoplasticUterine Cervical DysplasiaUterine Cervical NeoplasmsCesarean SectionColposcopyFemaleHumansPregnancyPregnant PeopleRetrospective StudiesVaginal SmearsCervical cancerDysplasiaPregnancy

Identifiers

PMID35976386
PMCPMC9633466
OpenAlexW4292289375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.